Conclusions
weight loss, hypoglycaemia
TYPE 2 DIABETES, HYPOGLYCAEMIA
Insulin treatment simplification with IDegLira in selected patients with type 2 diabetes is safe, maintains adequate glycaemic control and is associated with weight loss over 12 months.Simplification of insulin regimens is suitable for a lot of people with type 2 diabetes, but it is rarely carried out. Overtreatment is present when HbA1c is low and hypoglycaemia risk is high and when HbA1c is optimal, but the patient is using unnecessarily complex treatment instead of simpler alternatives. Once daily IDegLira is a potential tool for insulin treatment simplification. We demonstrated that switching from complex insulin regimens to IDegLira in selected overtreated patients is safe, induces weight loss and results in similar or better glycaemic control in the long term.

